High-sensitivity troponin tests for early rule out of NSTEMI

The National Institute for Health and Care Excellence has published guidance on high-sensitivity troponin tests for early rule out of non-ST-segment elevation myocardial infarction (NSTEMI), recommending assays such as Beckman Coulter’s Access hsTnI.

Combining a high-sensitive troponin assay with a rapid rule-out protocol quickly indicates if a person has a myocardial infarction or not. Therefore, the hsTnI helps both the patient and the hospital, leading to reduced waiting times for patients, while also allowing hospitals to deliver safe, high-quality urgent and emergency care.

National Institute for Health and Care Excellence (NICE) guidance also references the 2020 European Society of Cardiology (ESC) guidance, where high-sensitivity cardiac troponin tests with validated 0/1 h and 0/2 h algorithms are now cited as a Class I recommendation for diagnosis using rapid ‘rule-in’ and ‘rule-out’ algorithms. Beckman Coulter’s Access hsTnI I is listed with assay-specific cut-offs for both 0/1 h and 0/2 h algorithms, delivering reliable results that clinicians can use with confidence to make decisions about patient management.

www.beckmancoulter.com

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022